Lab to £30m+ in Revenue and a $310m Exit | Eric Mayes
Eric Mayes, Chief Executive Officer, Endomag
Podcast Episode Description:
In this episode of Lab to Market Leadership, host Chris Reichhelm speaks with Eric Mayes, PhD, former CEO of Endomag, to explore the full Lab-to-Market journey of this innovative Medtech startup.
Eric shares how Endomag transformed from a university spinout into a global leader in breast cancer innovation. Drawing on his experience leading the company to product-market fit, profitability, and a $310 million acquisition by Hologic, Eric provides invaluable insights into navigating regulatory hurdles, scaling Medtech solutions, and building resilient teams.
Discover how Endomag’s innovative technology, strategic partnerships, and leadership culture created global clinical impact, setting the company on a path to scale and commercial success. This episode offers a masterclass in overcoming the unique challenges of Deep Tech commercialisation, making it a must-listen for Medtech entrepreneurs, investors, and anyone navigating the Lab-to-Market journey.
Key Topics from the Show:
From university spinout to a global Medtech leader: The Lab-to-Market journey of Endomag
Navigating regulatory landscapes and securing device classification for faster market entry
Scaling Medtech solutions to achieve commercial viability and market impact
How customer feedback and clinical collaboration shaped Endomag’s innovations
Building a culture of learning: Team education as a foundation for success in Deep Tech
The pivotal role of leadership in overcoming existential challenges
Lessons learned from Endomag’s $310 million acquisition by Hologic
Podcast Chapter Notes:
0:00 – Introduction to the episode and Eric Mayes’ career journey in Deep Tech
3:20 – Overcoming early challenges: Navigating regulatory landscapes and funding hurdles
12:00 – Building and scaling Medtech solutions for breast cancer surgery
22:30 – Fostering a culture of education and clinical understanding across the team
36:40 – Transitioning to direct sales in Europe and scaling revenues to £30m+
49:00 – Insights from the $310 million acquisition by Hologic and the future of breast cancer innovation
Subscribe to our technology leadership podcast on YouTube or wherever you get your podcasts to stay updated on Medtech innovation and the latest insights from Deep Tech innovators.
To learn more about Lab-to-Market Leadership, view our presentation: ‘The Lab-to-Market Journey – a Blueprint.’
Additionally, learn about our work with CEOs.
